Alignment Healthcare, Inc. (ALHC) stock
ALHCNasdaqHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3053% above fair value
$7.62+0.15 (+2.01%)
Close on Nov 17, 2026Market cap $1.59BP/E 69.3Yield –
Alignment Healthcare total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Alignment Healthcare's total debt was $324.50M at Sep 30, 2026. For fiscal 2025 it was $323.18M, up 0.5% from the year before. The highest annual figure on record is $323.18M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $323.18M | +0.5% |
| FY2024 | Dec 31, 2024 | $321.43M | +98.6% |
| FY2023 | Dec 31, 2023 | $161.81M | +0.6% |
| FY2022 | Dec 31, 2022 | $160.90M | +6.8% |
| FY2021 | Dec 31, 2021 | $150.62M | +4.5% |
| FY2020 | Dec 31, 2020 | $144.17M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $324.50M | +0.5% |
| Q2 FY2026 | Jun 30, 2026 | $324.06M | +0.5% |
| Q1 FY2026 | Mar 31, 2026 | $323.62M | +0.5% |
| Q4 FY2025 | Dec 31, 2025 | $323.18M | +0.5% |
| Q3 FY2025 | Sep 30, 2025 | $322.74M | +52.2% |
| Q2 FY2025 | Jun 30, 2025 | $322.30M | +52.2% |
| Q1 FY2025 | Mar 31, 2025 | $321.86M | +98.6% |
| Q4 FY2024 | Dec 31, 2024 | $321.43M | +98.6% |
| Q3 FY2024 | Sep 30, 2024 | $212.00M | +31.2% |
| Q2 FY2024 | Jun 30, 2024 | $211.74M | +31.2% |
| Q1 FY2024 | Mar 31, 2024 | $162.03M | +0.6% |
| Q4 FY2023 | Dec 31, 2023 | $161.81M | +0.6% |
| Q3 FY2023 | Sep 30, 2023 | $161.60M | +0.6% |
| Q2 FY2023 | Jun 30, 2023 | $161.38M | +4.8% |
| Q1 FY2023 | Mar 31, 2023 | $161.12M | +5.8% |
| Q4 FY2022 | Dec 31, 2022 | $160.90M | +6.8% |
| Q3 FY2022 | Sep 30, 2022 | $160.68M | +7.9% |
| Q2 FY2022 | Jun 30, 2022 | $153.93M | +4.5% |
| Q1 FY2022 | Mar 31, 2022 | $152.26M | +4.5% |
| Q4 FY2021 | Dec 31, 2021 | $150.62M | +4.5% |
| Q3 FY2021 | Sep 30, 2021 | $148.97M | – |
| Q2 FY2021 | Jun 30, 2021 | $147.33M | – |
| Q1 FY2021 | Mar 31, 2021 | $145.73M | – |
| Q4 FY2020 | Dec 31, 2020 | $144.17M | – |
See a number that looks wrong?